An interesting note in a Huntley daily update caught my attention today.
The note went roughly as follows:-
Shares in Genentech jumped 24.8%. This was after an analysis of a Phase III trial showed the company's Avastin treatment plus chemotherapy extended the survival of patients with certain lung cancers. The advance added roughly $11 billion to the value of investors' holdings in the stock.
Genentech is a very big company, but an $11 billion jump in capitilisation is just breathtaking.
Poor old Solbec is sitting at roughly $22 million in capitalisation (excluding options), just simply no comparison.
I would love (just dreaming) to see Solbec rise by even 1% of the rise that Genentech (that would be a five fold jump in sp).
- Forums
- ASX - By Stock
- SBP
- genentech up $11 billion
SBP
solbec pharmaceuticals limited
genentech up $11 billion
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online